Kidney outcomes in SGLT2 inhibitor outcome trials in patients with T2D

Overview of kidney outcomes in patients with T2D from SGLT2 inhibitor trials.

Kidney outcomes in SGLT2 inhibitor outcome trials in patients with T2D
Rate this content
  • Kidney outcomes in SGLT2 inhibitor outcome trials in patients with T2D
  • Kidney outcomes in SGLT2 inhibitor outcome trials in patients with T2D
  • Patients with diabetes are at high risk of kidney disease
  • Intensive glucose control is associated with a 20% RRR in kidney events in patients with T2D
  • DKD-specific treatments that have been approved for slowing the progression of nephropathy in the past two decades
Do you want to go to the Presentation Builder section to create a new presentation?
Cancel Go